Skip to main content

LPL Financial Welcomes Emerald Wealth Management

SAN DIEGO, May 21, 2026 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that the financial advisors of Emerald Wealth Management have joined LPL Financial’s broker-dealer and Registered Investment Advisor (RIA) platform. The team reports serving approximately $815 million in advisory, brokerage, insurance and retirement plan assets* and joins LPL from Northwestern Mutual. Emerald Wealth is led by Darren Trautmann, founder and private wealth advisor and Brendan Foor, private wealth advisor. The advisory team also includes Carson Hill, CFP®, ChFC®, Ben Pawlak, RICP® and Ben Chen. Based in Seattle, the team serves a diverse client base that includes professionals in the technology sector, as well as individuals and families nearing or entering retirement. The firm is built on a comprehensive, client-centered approach that goes...

Continue reading

Reliable Caps, PureCycle Partner to Offer Closures for Contact-Sensitive Applications Using PureFive® Recycled Polypropylene

Bright white, colorable closures made with certified, domestically sourced post-consumer recycled (PCR) content to address growing regulatory demand ORLANDO, Fla., May 21, 2026 (GLOBE NEWSWIRE) — PureCycle Technologies, Inc. (Nasdaq: PCT), a U.S.-based company revolutionizing plastic recycling, today announced a partnership with Reliable Caps, a leading manufacturer of caps and closures for consumer and industrial packaging. Reliable Caps used PureFive Ultra™ resin to produce white closures with up to 75% certified PCR content. The achievement positions Reliable Caps as one of the first converters in the industry to use PureFive® resin in a contact-sensitive application where regulatory demands continue to grow. Reliable Caps’ closures made with PureFive® resin are available now through Reliable Caps’ distribution network....

Continue reading

Akari Therapeutics Announces $5.5 Million Private Placement Offering

TAMPA, Fla. and LONDON, May 21, 2026 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with a novel RNA splicing modulator payload, today announced the successful pricing of a private placement financing round. This transaction is expected to raise an aggregate of approximately $5.5 million in gross proceeds. With these funds the Company will focus on advancing its lead ADC program utilizing its unique RNA splicing modulator payload, AKTX-101, toward a first-in-human Phase 1 clinical trial. “This financing reflects deep conviction from our long-term strategic investors and positions Akari to build on our strong momentum to accelerate our lead ADC program towards clinical data, pursue strategic partnerships, and unlock the full potential of our...

Continue reading

Tenable Launches Open Partner Exchange Network (OPEN) to Connect Security Tools, Data and AI-Driven Workflows Across the Enterprise

Open ecosystem initiative enables connected workflows, richer context and coordinated remediation across security environments BOSTON, May 21, 2026 (GLOBE NEWSWIRE) — Tenable® Holdings, Inc. (NASDAQ: TENB), the exposure management company, today announced the Tenable Open Partner Exchange Network (OPEN), the next evolution of its technology partner ecosystem, designed to help organizations unify security data, accelerate AI-driven workflows, and operationalize exposure management across their existing technology stack. As AI accelerates the speed and scale of cyber threats, security teams are struggling with fragmented tools, disconnected workflows, and growing operational complexity. Tenable OPEN extends the power of the Tenable One Exposure Management Platform through an open ecosystem of integrations, data exchange, and orchestration...

Continue reading

Concrete Pumping Holdings Sets Second Quarter 2026 Earnings Conference Call for Thursday, June 4, 2026

DENVER, May 21, 2026 (GLOBE NEWSWIRE) — Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) (“CPH” or the “Company”), a leading provider of concrete pumping and waste management services in the U.S. and U.K., will hold a conference call on Thursday, June 4, 2026, at 5:00 p.m. Eastern Time to discuss its financial results for the second quarter ended April 30, 2026. The Company will report its financial results in a press release prior to the conference call. CPH’s CEO Bruce Young and CFO Iain Humphries will host the conference call, followed by a question-and-answer period. Date: Thursday, June 4, 2026Time: 5:00 p.m. Eastern Time (3:00 p.m. Mountain Time)Toll-free dial-in number: 1-877-407-9039International dial-in number: 1-201-689-8470Conference ID: 13760380 Please call the conference telephone number 5-10 minutes prior to the start...

Continue reading

Weatherford Awarded Deepwater Integrated Completions Contract with ExxonMobil in Nigeria

HOUSTON, May 21, 2026 (GLOBE NEWSWIRE) — Weatherford International plc (NASDAQ: WFRD) (“Weatherford” or the “Company”) today announced it has been awarded a deepwater integrated completions contract by Esso Exploration & Production Nigeria Ltd. (“EEPNL”), an ExxonMobil affiliate, for offshore Nigeria. The contract falls within Weatherford’s Well Construction and Completions portfolio. Weatherford will provide integrated upper and lower completions solutions for deepwater wells, with a scope focused on supporting safety, reliability, well integrity, and operational efficiency over the lifecycle of the well. The integrated completions equipment will be configured and prepared through Weatherford’s global supply chain and supported locally in Nigeria, in line with contract terms, to enable in-country execution and service delivery. Girish...

Continue reading

Lantheus Highlights New Radiodiagnostic Data at the 2026 SNMMI Annual Meeting

BEDFORD, Mass., May 21, 2026 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announced new radiodiagnostic data to be presented at the 2026 Society of Nuclear Medicine and Medical Imaging (SNMMI) Annual Meeting, taking place May 30 – June 2, 2026 in Los Angeles, CA. Presentation details are as follows: Date & Time: Monday, June 1, 2026, 10:30 am – 11:15 am PT Session Type: PosterSession Title:  Oncology Clinical Diagnosis and Therapy Scientific Session Session Number: MTA06 – Screen 29Title: Impact of PSMA-PET with Piflufolastat F18 on Prostate Cancer Management for Patients with Low or Ultra-low Prostate-Specific Antigen Levels after Definitive Treatment.Presenter: Neal...

Continue reading

IperionX Commissions Six-Axis Powder Metallurgy Press, Expanding U.S. Titanium Component Manufacturing Capabilities

Commissioned advanced 300-ton, six-axis SACMI powder metallurgy press at IperionX’s Titanium Manufacturing Campus in South Boston, Virginia Triples IperionX’s existing powder metallurgy capacity and materially expands the range of high-value titanium powder-to-product components that can be manufactured in the United States Significantly enhances product flexibility and production repeatability, enabling more complex near-net-shape titanium components including fasteners, gears, brackets, actuators and other high-value defense, aerospace and industrial parts High-productivity titanium manufacturing platform capable of up to 24 pressing cycles per minute, equivalent to approximately 11 million single-cavity parts per year under operating assumptions, with higher part rates achievable using multi-cavity tooling for simpler components Designed...

Continue reading

Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of Veterans Affairs for Traumatic Brain Injury

U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury Report language, championed through the Nexalin America division, builds on Nexalin’s ongoing UC San Diego / San Diego VA-related TBI clinical research program Marks second Congressional action this year referencing non-invasive deep brain neurostimulation as an emerging therapy for veterans HOUSTON, TX, May 21, 2026 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) of the brain, celebrates the inclusion of report language that Nexalin America directly advocated, that promotes additional research...

Continue reading

Duos Technologies to Participate at the 23rd Annual Craig-Hallum Institutional Investor Conference

JACKSONVILLE, Fla., May 21, 2026 (GLOBE NEWSWIRE) — Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT), a provider of modular, colocation Edge and AI data centers and technology infrastructure solutions, today announced that Company management will be participating at the upcoming 23rd Annual Craig-Hallum Institutional Investor Conference being held on Thursday, May 28, 2026 at the Depot Renaissance Hotel in Minneapolis, MN. Duos management will be available for one-on-one and small group meetings with institutional investors throughout the conference. Those interested in scheduling a meeting with Duos management should contact their Craig-Hallum representative or the investor relations contact listed below. For more information, please visit the Craig-Hallum conference website. About Duos Technologies Group,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.